Home > Boards > US Listed > Biotechs > BioMarin Pharmaceutical Inc. (BMRN)

Could the FDA Approve Both BioMarin and Sarepta’s

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
trendmkr Member Profile
 
Followed By 12
Posts 911
Boards Moderated 0
Alias Born 05/29/15
160x600 placeholder
European Medicines Agency Validates BioMarin's Marketing Authorization Application for Vosoritide to Treat Children with Acho... PR Newswire (US) - 8/13/2020 8:31:00 AM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 8/10/2020 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2020 6:56:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2020 6:01:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 4:10:07 PM
BioMarin Announces Second Quarter 2020 Total Revenue Growth of 11% to $430 million PR Newswire (US) - 8/4/2020 4:05:00 PM
BioMarin Submits Marketing Authorization Application to European Medicines Agency for Vosoritide to Treat Children with Achon... PR Newswire (US) - 7/23/2020 4:07:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/22/2020 5:32:41 PM
BioMarin to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 4 at 4:30pm ET PR Newswire (US) - 7/21/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2020 3:01:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2020 2:12:01 PM
BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO PR Newswire (US) - 6/29/2020 4:16:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 7:25:40 PM
BioMarin to Participate in the Virtual BofA Securities 2020 Napa Biopharma Conference PR Newswire (US) - 6/23/2020 8:30:00 AM
uniQure Announces the Appointment of Leonard E. Post, Ph.D. to its Board of Directors GlobeNewswire Inc. - 6/17/2020 4:05:10 PM
BioMarin Provides Additional Data from Recent 4 Year Update of Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene The... PR Newswire (US) - 6/17/2020 9:20:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2020 6:04:44 PM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 6/3/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2020 4:16:57 PM
BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Ther... PR Newswire (US) - 5/31/2020 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:49:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:33:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:08:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 5:39:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 5:10:28 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist